Table 3.
Neonatal Biomarkersa | Obese Class II/III | Obese Class I | Overweight | |||
---|---|---|---|---|---|---|
(>35.0 kg/m2) | (30.0-34.9 kg/m2) | (25.0-29.9 kg/m2) | ||||
Total n = 3555 | n = 379 | n = 666 | n = 1551 | |||
Unadjusted | Adjusted | Unadjusted | Adjusted | Unadjusted | Adjusted | |
Inflammation score | 0.08 (−0.08,0.23) | 0.07 (−0.09,0.23) | 0.03 (−0.09,0.15) | 0.05 (−0.07,0.17) | −0.03 (−0.13,0.08) | 0.003 (−0.10,0.11) |
CRPb | 0.01 (−0.08,0.11) | 0.004 (−0.10,0.10) | 0.01 (−0.07,0.09) | 0.01 (−0.07,0.09) | 0.005 (−0.06,0.07) | 0.02 (−0.04,0.09) |
IgEc | 0.04 (−0.06,0.14) | 0.04 (−0.06,0.15) | −0.02 (−0.10,0.06) | −0.02 (−0.10,0.07) | 0.01 (−0.06,0.08) | 0.01 (−0.06,0.08) |
IgAc | 0.002 (−0.06,0.07) | 0.02 (−0.05,0.09) | −0.03 (−0.09,0.03) | −0.01 (−0.07,0.05) | −0.01 (−0.06,0.04) | −0.0001 (−0.05,0.05) |
IgMc | −0.08 (−0.15,−0.01) | −0.11 (−0.19,−0.04) | −0.05 (−0.11,0.01) | −0.07 (−0.13,−0.01) | −0.07 (−0.12,−0.03) | −0.08 (−0.13,−0.03) |
IgG1c | −0.04 (−0.08,0.0005) | −0.03 (−0.07,0.02) | −0.01 (−0.04,0.02) | −0.001 (−0.03,0.03) | 0.005 (−0.02,0.03) | 0.01 (−0.02,0.04) |
IgG2c | −0.01 (−0.10,0.08) | −0.03 (−0.12,0.06) | −0.04 (−0.11,0.03) | −0.06 (−0.13,0.02) | 0.02 (−0.03,0.08) | 0.01 (−0.04,0.07) |
IgG3c | −0.07 (−0.15,0.01) | −0.05 (−0.13,0.04) | −0.07 (−0.12,−0.01) | −0.04 (−0.10,0.02) | −0.03 (−0.08,0.02) | −0.01 (−0.06,0.04) |
IgG4c | −0.09 (−0.27,0.08) | −0.03 (−0.21,0.15) | −0.01 (−0.14,0.12) | 0.02 (−0.11,0.15) | 0.06 (−0.06,0.18) | 0.08 (−0.04,0.19) |
Abbreviations: CI, confidence interval; CRP, C-reactive protein; TNF, tumor necrosis factor; (IL)-1ra, interleukin-1 receptor antagonist; Ig, immunoglobulin.
Adjusted for maternal age; white race; attainment of college degree or higher; private insurance; smoking and alcohol use during pregnancy; parity; infant plurality; and pre-pregnancy body mass index. Significant differences (P<0.05) are in bold.
Infants born to thin and normal weight men (body mass index= <25.0 kg/m2) served as the reference group: n=959.
log mg/L
log ng/mL